Abstracts

POTENTIAL IMPACT & COST-EFFECTIVENESS OF WIDELY ACCESSIBLE TLD IN SUB-SAHARAN AFRICA

Background: Post-exposure prophylaxis (PEP) offers protection from HIV after unanticipated condomless sex, but is not widely available in a timely way in sub-Saharan Africa (SSA). We propose consideration of making tenofovir-lamivudine-dolutegravir (TLD) widely and freely locally available in communities without prescription (e.g. where condoms are made available, along with HIV self-test kits and emergency contraception),…

SPECIFIC EXOSOMAL PROTEOMIC PROFILE ASSOCIATED TO PLWH PRESENTING NADCs

Background: People living with HIV have an increased risk of developing different types of cancers (NADC:Non-Aids Defining Cancers).However, it is poorly understood the underlying mechanisms that link up HIV infection with the development and progression of these cancers.Previous in vitro studies have suggested that exosomes derived from HIV infected cells can promote and enhance cancer.Herein,…

PATTERNS OF HIV-1 RECENT INFECTION AMONG GENERAL AND KEY POPULATIONS IN NIGERIA

Background: HIV-1 Recent Infection Testing Algorithm (RITA) is increasingly applied to population-based surveys in numerous countries for population level estimates of HIV incidence. Nigeria commenced implementation of recency surveillance in 2020 and preliminary data for estimating state and national level HIV incidence is becoming available. The aim of the study is to understand the patterns…

GLOBAL COLLABORATION TO PROVIDE DRUG INTERACTION GUIDANCE FOR NIRMATRELVIR/RITONAVIR

Background: Nirmatrelvir/ritonavir (NMV/r), a preferred antiviral for high-risk outpatients with COVID-19, is associated with major drug-drug interactions (DDIs). Given the lack of DDI data with short course ritonavir (RTV), initial NMV/r product information was extrapolated from chronic, full dose RTV use. In Jan 2022, DDI experts from the University of Liverpool (UoL), NIH COVID-19 Guidelines…